Potential of the cell therapy for unmet medical needs

  Chis Mason, PhD (University of London), presented the potential of the cell therapy industry to become a multibillion dollar industry as a result of R&D, investment and media coverage. Emphasizing the difference between cell therapy and regenerative medicine, he spoke about the need to distinguish the two fields and allow them to grow to their full potential. Mason touted cell therapies as potentially revolutionary solutions for unmet medical needs and called for an effective business model to bring these therapies to market. Watch Presentation from 2011 World Stem Cell Summit: “Cell Therapy, Billion Dollar Global Business, Unlimited Potential, Chris Mason, PhD”   Further Reading and Related Videos 2012 World Stem Cell Summit 2011 Summit:…

State agency plans cell line bank

Stem cell agency plans cell line bank California’s stem cell research funding agency wants to make a $30 million investment in the banking business. The California Institute for Regenerative Medicine’s three-part strategy ultimately will create a stem cell bank for so-called pluripotent stem cells that can be manipulated to form skin, heart or other types of cells. It would allow researchers to more quickly and efficiently create “disease-in-a-dish” models of genetically complex diseases like diabetes, asthma, autism or heart disease. Although the bank would house some embryonic stem cell lines, the project’s emphasis is on the fast-moving field of induced pluripotent stem cells, or IPS cells. via Stem cell agency plans cell line bank –…

Cord Blood Banking Perspectives

Inside the Strange Science of Cord Blood Banking Over one hundred thousand families save or donate cord blood annually, in the hopes it will one day provide medical help to their child or someone else. But while banking cord blood is legal and safe, many health care professionals question the value of private banks. Regenerative therapies based on stem cells from cord blood have had mixed preliminary success, and researchers are split over when and whether they’ll ever come through. Using cord blood medically began in Paris in 1988 with a transplantation to regenerate blood and immune cells in a young child with Fanconi’s anemia, a blood disorder. The blood came from the umbilical cord…

Stem cell banks may be in our future

You’ve heard of blood banks- even sperm banks. Now, stem cell banks may one day be a possibility. Researchers in San Antonio are zeroing in on a fascinating finding. Stem cells, that have the potential to be bones, muscles and nerves are less numerous as we age, but if they’re placed in a dish with a natural matrix of proteins, from a younger organism, they regenerate and regain their youthful power.  Watch News Story Link to Video       Recommend on FacebookTell a friend

Stem Cell Banking: The Perspective of an iPS Donor Family

“Your twin daughters have an extremely rare, fatal disease called Niemann Pick Type C and there’s nothing you can do for them”. Those were the devastating words that Chris Hempel and her husband first heard in 2007. Rather than just give in to this fate, the Hempels are proactively engaging researchers to try to save Addi and Cassi’s lives. This journey includes donating skin samples to cell banks so that researchers can create induced pluripotent stem (iPS) cells, a promising technology which may help undercover treatments for their daughters. In this video, Chris Hempel speaks to the CIRM Standards Working Group to present a patient advocate’s perspective on the challenges of rare disease research. Hempel…